Skip to content
Triangle logo TriangleGet started
← Full study record

NCT01083602 · OUTCOME

Time to Progression

Efficacy of Panobinostat in Patients With Relapsed and Bortezomib-refractory Multiple Myeloma · Source last updated 2017-12-21

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
MEDIAN
Unit
Days
Interval / dispersion
95% Confidence Interval
Time frame
24 weeks

What was measured

Time from randomization until objective tumor progression; does not include deaths-- Kaplan-Meier estimates

Analysis population: FAS

Groups in this outcome

Panobinostat + Bortezomib & Dexamethasone

panobinostat in combination with bortezomib and dexamethasone in patients with relapsed and bortezomib-refractory multiple myeloma

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Panobinostat + Bortezomib & Dexamethasone55

Reported measurements

Source class 1
Values in Days · Interval/dispersion: 95% Confidence Interval
GroupValueSpreadLowerUpperComment
Panobinostat + Bortezomib & Dexamethasone164.0Not reported107.0204.0Not reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        107.0
        upper Limit
        204.0
        value
        164.0
denoms
  1. counts
    1. group Id
      OG000
      value
      55
    units
    Participants
description
Time from randomization until objective tumor progression; does not include deaths-- Kaplan-Meier estimates
dispersion Type
95% Confidence Interval
groups
  1. description
    panobinostat in combination with bortezomib and dexamethasone in patients with relapsed and bortezomib-refractory multiple myeloma
    id
    OG000
    title
    Panobinostat + Bortezomib & Dexamethasone
param Type
MEDIAN
population Description
FAS
reporting Status
POSTED
time Frame
24 weeks
title
Time to Progression
type
SECONDARY
unit Of Measure
Days

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice